Loss of AMP-activated protein kinase induces mitochondrial dysfunction and proinflammatory response in unstimulated Abcd1-knockout mice mixed glial cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Singh, Jaspreet ^a   Suhail, Hamid ^a   Giri, Shailendra ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C OXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOCHONDRIAL COMPLEX V; MITOCHONDRIAL PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCD1 PROTEIN, MOUSE; AMPK ALPHA1 SUBUNIT, MOUSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ADRENOLEUKODYSTROPHY; AMP ACTIVATED PROTEIN KINASE ALPHA 1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MITOCHONDRION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE; GENE DELETION; GENE LOSS; GENETIC ASSOCIATION; GLIA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; WILD TYPE; ANIMAL; CELL CULTURE; GLIA; IMMUNOLOGY; MITOCHONDRION; PHYSIOLOGY;

MUS;

ADRENOLEUKODYSTROPHY; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; HUMANS; INFLAMMATION; MICE; MICE, KNOCKOUT; MITOCHONDRIA; NEUROGLIA;

EID: 84925607535     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/176983     Document Type: Article

References (35)

1. S. Kemp, J. Berger, and P. Aubourg, "X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects," Biochimica et BiophysicaActa, vol. 1822, no. 9, pp. 1465-1474, 2012.
2. M. Contreras, J. Mosser, J. L. Mandel, P. Aubourg, and I. Singh, "The protein coded by the X-adenoleukodystrophy gene is a peroxisomal integralmembrane protein," FEBS Letters, vol. 344, no. 2-3, pp. 211-215, 1994.
3. M. Engelen, S. Kemp, M. de Visser et al., "X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up andmanagement," Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 51, 2012.
4. I. Singh and A. Pujol, "Pathomechanisms underlying Xadrenoleukodystrophy: a three-hit hypothesis," Brain Pathology, vol. 20, no. 4, pp. 838-844, 2010.
5. J.-F. Lu, A. M. Lawler, P. A. Watkins et al., "A mouse model forX-linked adrenoleukodystrophy," Proceedings of theNational Academy of Sciences of the United States of America, vol. 94, no. 17, pp. 9366-9371, 1997.
6. T. Kobayashi, N. Shinnoh, A. Kondo, and T. Yamada, "Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism," Biochemical and Biophysical Research Communications, vol. 232, no. 3, pp. 631-636, 1997.
7. S. Forss-Petter, H. Werner, J. Berger et al., "Targeted inactivation of the X-linked adrenoleukodystrophy gene in mice," Journal of Neuroscience Research, vol. 50, no. 5, pp. 829-843, 1997.
8. A. Pujol, C. Hindelang, N. Callizot, U. Bartsch, M. Schachner, and J. L. Mandel, "Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy," HumanMolecular Genetics, vol. 11, no. 5, pp. 499-505, 2002.
9. J. Singh and S. Giri, "Loss of AMP-activated protein kinase in X-linked adrenoleukodystrophy patient-derived fibroblasts and lymphocytes," Biochemical and Biophysical Research Communications, vol. 445, no. 1, pp. 126-131, 2014.
10. K. C. Carroll, B. Viollet, and J. Suttles, "AMPKalpha1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling," Journal of Leukocyte Biology, vol. 94, no. 6, pp. 1113-1121, 2013.
11. N. Nath, M. Khan, R. Rattan et al., "Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity," Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 16-20, 2009.
12. L. A. J. O'Neill and D. Grahame Hardie, "Metabolism of inflammation limited by AMPK and pseudo-starvation," Nature, vol. 493, no. 7432, pp. 346-355, 2013.
13. N. Nath, M. Khan, M. K. Paintlia, I. Singh, M. N. Hoda, and S. Giri, "Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis," The Journal of Immunology, vol. 182, pp. 8005-8014, 2009.
14. N. Nath, S. Giri, R. Prasad, M. L. Salem, A. K. Singh, and I. Singh, "5-Aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis,"The Journal of Immunology, vol. 175, no. 1, pp. 566-574, 2005.
15. H. M. O'Neill, S. J. Maarbjerg, J. D. Crane et al., "AMP-activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 38, pp. 16092-16097, 2011.
16. J. Singh, M. Khan, and I. Singh, "Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for Xadrenoleukodystrophy," Journal of Lipid Research, vol. 50, no. 1, pp. 135-147, 2009.
17. N. Nath, M. Khan, R. Rattan et al., "Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity," Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 16-20, 2009.
18. S. Galic, M. D. Fullerton, J. D. Schertzer et al., "Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity," Journal of Clinical Investigation, vol. 121, no. 12, pp. 4903-4915, 2011.
19. R. Mounier, M. Théret, L. Arnold et al., "AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration," Cell Metabolism, vol. 18, no. 2, pp. 251-264, 2013.
20. J. Singh, M. Khan, A. Pujol, M. Baarine, and I. Singh, "Histone deacetylase inhibitor upregulates peroxisomal fatty acid oxidation and inhibits apoptotic cell death in abcd1-deficient glial cells," PLoS ONE, vol. 8, no. 7, Article ID e70712, 2013.
21. S. Fourcade, J. López-Erauskin, M. Ruiz, I. Ferrer, and A. Pujol, "Mitochondrial dysfunction and oxidative damage cooperatively fuel axonal degeneration in X-linked adrenoleukodystrophy," Biochimie, vol. 98, no. 1, pp. 143-149, 2014.
22. J. Berger, S. Forss-Petter, and F. S. Eichler, "Pathophysiology of X-linked adrenoleukodystrophy," Biochimie, vol. 98, no. 1, pp. 135-142, 2014.
23. L. De Meirleir, S. Seneca, W. Lissens et al., "Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12," Journal of Medical Genetics, vol. 41, no. 2, pp. 120-124, 2004.
24. X. Zhu, X. Peng, M. X. Guan, and Q. Yan, "Pathogenicmutations of nuclear genes associated with mitochondrial disorders," Acta Biochimica et Biophysica Sinica, vol. 41, no. 3, pp. 179-187, 2009.
25. R. H. Triepels, L. P. van den Heuvel, J. L. C. M. Loeffen et al., "Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I," Annals of Neurology, vol. 45, no. 6, pp. 787-790, 1999.
26. J. Smeitink and L. van den Heuvel, "Human mitochondrial complex I in health and disease," The American Journal of Human Genetics, vol. 64, no. 6, pp. 1505-1510, 1999.
27. P. Bénit, D. Chretien, N. Kadhom et al., "Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes inmitochondrial complex I deficiency," American Journal of Human Genetics, vol. 68, no. 6, pp. 1344-1352, 2001.
28. T. Bourgeron, P. Rustin, D. Chretien et al., "Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency," Nature Genetics, vol. 11, no. 2, pp. 144-149, 1995.
29. A. I. Jonckheere, G. Herma Renkema, M. Bras et al., "A complex v ATP5A1 defect causes fatal neonatal mitochondrial encephalopathy," Brain, vol. 136, no. 5, pp. 1544-1554, 2013.
30. P. J. Fernandez-Marcos and J. Auwerx, "Regulation of PGC- 1alpha, a nodal regulator of mitochondrial biogenesis," The American Journal of Clinical Nutrition, vol. 93, no. 4, pp. 884S- 890S, 2011.
31. R. C. Scarpulla, "Metabolic control ofmitochondrial biogenesis through the PGC-1 family regulatory network," Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1269-1278, 2011.
32. M. B. de Moura and B. van Houten, "Bioenergetic analysis of intact mammalian cells using the seahorse XF24 extracellular flux analyzer and a luciferase ATP assay," in Molecular Toxicology Protocols, vol. 1105 ofMethods inMolecular Biology, pp. 589-602, Humana Press, 2014.
33. F. Reinecke, J. A. M. Smeitink, and F. H. van der Westhuizen, "OXPHOS gene expression and control inmitochondrial disorders," Biochimica et Biophysica Acta, vol. 1792, no. 12, pp. 1113-1121, 2009.
34. T. Matsukawa, M. Asheuer, Y. Takahashi et al., "Identification of novel SNPs of ABCD1, ABCD2, ABCD3, and ABCD4 genes in patients with X-linked adrenoleukodystrophy (ALD) based on comprehensive resequencing and association studies with ALD phenotypes," Neurogenetics, vol. 12, no. 1, pp. 41-50, 2011.
35. B. Viollet, Y. Athea, R. Mounier et al., "AMPK: lessons from transgenic and knockout animals," Frontiers in Bioscience (Landmark Ed), vol. 14, no. 1, pp. 19-44, 2009.